Table 3.

Laboratory peak data of advanced heart failure patients during hospitalization due to COVID‐19

Laboratory data	Mean peak (±1 DP)
White blood cell count (per microlitre) (nl range 3500–10 500) n (%) of pts with peak value > upper nl value	6796 ± 3193 3 (19%)
Lymphocyte count (per microlitre) (nl range 900–2900) n (%) of pts with lower number < nl value	856 ± 366 8 (50%)
White blood cell/lymphocyte count (range 3.62–3.89) n (%) of pts with peak > upper nl value	14 ± 24 13 (81%)
High‐sensitivity troponin T peak level (ng/mL) n (%) of pts with peak value >0.014 ng/mL	0.27 ± 0.23 16 (100%)
High‐sensitivity C‐reactive protein (<5 or 0.5 mg/dL) n (%) of pts with peak > upper nl value	91 ± 50 15 (94%)
d‐Dimer (μg/mL) (nl < 500 ng/mL) n (%) of pts with peak value > upper normal value	4877 ± 6900 15 (94%)
Serum creatinine levels (mg/dL) (nl man <1.3, woman <1.02) n (%) of pts with peak > nl upper value	1.49 ± 1.03 7 (44%)
Brain natriuretic peptide (pg/mL) (nl < 100) n (%) of pts with peak > nl upper value	4040 ± 5680 15 (94%)
Aspartate aminotransferase (U/L) (nl 15–37) n (%) of pts with peak > nl upper value	47 ± 52 5 (31%)
Alanine aminotransferase (U/L) (nl 14–57) n (%) of pts with peak > nl upper value	47 ± 76 3 (1%)
Ferritin (ng/mL) (nl value man 22–322, woman 15–190) n (%) of pts with peak > upper nl value	516 ± 385 10 pts (63%)
Fibrinogen (nl 200–400 mg/dL) n (%) of pts with peak > upper nl value	423 ± 172 7 (44%)
Platelet count (per microlitre) (nl 150 000–450 000) n (%) of pts with lower value < nl	187 733 ± 55 769 5 (31%)
Lactate dehydrogenase (U/L) (nl 81–234) n (%) of pts with peak > upper nl value	510 ± 248 15 (94%)

DP, standard deviation; n, number; nl, normal; pts, patients.